About
Proskope develops a blood-based diagnostic test that uses the immune system as a biosensor to detect colorectal cancer early, providing results within hours to enable timely intervention.
Explore Proskope's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.